FIELD: medicine; pharmaceutics.
SUBSTANCE: group of inventions relates to pharmaceutics, namely to compositions for eliminating acute inflammation in a subject in need thereof, and to a set of said purpose. Composition for eliminating acute inflammation in a subject in need thereof, wherein said composition consists of the following ingredients: Achillea millefolium, Aconitum napellus, Arnica montana, Atropa bella-donna, Bellis perennis, Calendula officinalis, Echinacea purpurea, Echinacea, Hamamelis virginiana, Hepar sulfuris, Hypericum perforatum, Matricaria recutita, Mercurius solubilis Hahnemanni and Symphytum officinale, as well as a pharmaceutically acceptable carrier and/or diluent, wherein said ingredients of the composition are used in the following homoeopathic dilutions: Achillea millefolium D3, Aconitum napellus D2, Arnica montana D2, Atropa bella-donna D2, Bellis perennis D2, Calendula officinalis D2, Echinacea purpurea D2, Echinacea D2, Hamamelis virginiana D1, Hepar sulfuris D6, Hypericum perforatum D2, Matricaria recutita D3, Mercurius solubilis Hahnemanni D6 and Symphytum officinale D6. Pharmaceutical composition for eliminating acute inflammation in a subject in need thereof, comprising said composition and a non-steroidal anti-inflammatory drug (NSAID), where said NSAID is selected from the group consisting of salicylates, and preferably aspirin, diflunisal, salicylic acid and other salicylates, salsalates, propionic acid derivatives, and preferably ibuprofen, dexibuprofen, fenoprofen, ketoprofen, dexketoprofen, flurbiprofen, oxaprozin, loxoprofen, acetic acid derivatives, and preferably indomethacin, tolmetin, sulindac, etodolac, ketorolac, diclofenac, aceclofenac, nabumetone, enolic acid derivatives (oxicam), and preferably piroxicam, meloxicam, tenoxicam, droxicam, lornoxicam, phenylbutazone, anthranilic acid derivatives (fenamates), and preferably mefenamic acid, meclofenamic acid, flufenamic acid, tolfenamic acid, and selective COX-2 inhibitors (coxibs), preferably celecoxib, parecoxib and etoricoxib. Kit for eliminating acute inflammation in a subject in need thereof, comprising a composition selected from the above, and a non-steroidal anti-inflammatory drug (NSAID), wherein said NSAID is selected from the group consisting of salicylates, and preferably aspirin, diflunisal, salicylic acid and other salicylates, salsalates, propionic acid derivatives, and preferably ibuprofen, dexibuprofen, fenoprofen, ketoprofen, dexketoprofen, flurbiprofen, oxaprozin, loxoprofen, acetic acid derivatives, and preferably indomethacin, tolmetin, sulindac, etodolac, ketorolac, diclofenac, aceclofenac, nabumetone, enolic acid derivatives (oxicam), and preferably piroxicam, meloxicam, tenoxicam, droxicam, lornoxicam, phenylbutazone, anthranilic acid derivatives (fenamates), and preferably mefenamic acid, meclofenamic acid, flufenamic acid, tolfenamic acid, and selective COX-2 inhibitors (coxibs), preferably celecoxib, parecoxib and etoricoxib.
EFFECT: above group of inventions shows high efficiency in relation to inflammation elimination.
11 cl, 3 dwg, 1 tbl, 3 ex
